NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - Calvin Sandra

Filed: 2026-04-16 AccNo: 0001882909-26-000003 Size: 16 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/16 20:05 UTC
首次发现04/16 20:07 UTC
热度106.3
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 465 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001882909-26-000003

Filing Date: 2026-04-16

Accepted: 2026-04-16 16:05:10

Documents: 1

Period of Report: 2026-04-14

Travere Therapeutics, Inc. ( Issuer ) CIK : 0001438533 (see all company filings) EIN. : 262383102 | State of Incorp.: CA | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | form4-04162026_040403.xml | 4 | 15081